Drugs / CBD
last change Feb 2024 re-read 3 minutes ago

CBD

Developed for
osteoarthritis, knee
Investigated by
Northwell Health · Solace Brands, Inc.

Trials 1

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04412837 Oct 2022 → Dec 2023 osteoarthritis, knee Northwell Health Withdrawn No outcome recorded Stop: Business

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CBD ClinicalTrials.gov intervention name — accepted as the source's own label NCT04412837 ↗
Route Topical “CBD patch to be used topically” NCT04412837 ↗